Literature DB >> 6702418

Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.

H Jans, A Heltberg, I Zeeberg, J H Kristensen, T Fog, N E Raun.   

Abstract

Immune complexes (IC) have been found in both serum and cerebrospinal fluid (CSF) in multiple sclerosis (MS). The complement system is known to play a major role as a mediator of inflammation in immune complex disease. Therefore, we have investigated paired samples of serum and CSF from 32 patients with progressive MS for IC, the levels of the complement factors C4 and C3, and presence of their activation products (AP). IC was found in serum from 17 of the 32 MS patients (53%) and in CSF from 9 of 31 MS patients (29%). No correlation was found between the occurrence of IC in serum and in CSF. The levels of C3 in serum and CSF from the MS patients did not differ from the levels in a control group, whereas the levels of C4 in MS-serum were elevated and the C4 levels in MS-CSF reduced. A low level of CSF-C4 correlated significantly to the occurrence of CSF-IC. AP of C4 and C3 in serum were seen in 11 of the 32 patients (34%), appearing significantly more frequently among patients with circulating IC. No C4- or C3AP could be identified in CSF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702418     DOI: 10.1111/j.1600-0404.1984.tb07777.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Assessing the values of circulating immune complexes in multiple sclerosis patients following immunomodulator or corticosteroid treatment.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Anca Elena Gogu; Daniel Docu Axelerad
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

Review 2.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

3.  Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.

Authors:  J Roddy; I Clark; B L Hazleman; D A Compston; N J Scolding
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

Review 4.  An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases.

Authors:  B Paul Morgan; Jennifer L Gommerman; Valeria Ramaglia
Journal:  Front Cell Neurosci       Date:  2021-01-07       Impact factor: 5.505

5.  Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines.

Authors:  Renuka Natarajan; Sanna Hagman; Mari Hämälainen; Tiina Leppänen; Prasun Dastidar; Eeva Moilanen; Irina Elovaara
Journal:  Mult Scler Int       Date:  2015-11-08

Review 6.  Brain-Immune Interactions and Neuroinflammation After Traumatic Brain Injury.

Authors:  Virginie Dinet; Klaus G Petry; Jerome Badaut
Journal:  Front Neurosci       Date:  2019-11-12       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.